| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |